GL1X · GenesisL1 explorer

MolNFT v1 · #87791 · protein

Crystal structure of neural ectodermal development factor imp-L2.

4CBP · NEURAL/ECTODERMAL development factor imp-L2: “Crystal structure of neural ectodermal development factor imp-L2.”. X-ray diffraction, 4 pockets (best druggability 0.59). MolNFT v1 #87791 on GenesisL1: 3D structure, binding sites and…

PDB
4CBP
Type
protein
Length
413 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NEURAL/ECTODERMAL development factor imp-L2
UniProt
Q09024
Pockets
4 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 2% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANEURAL/ECTODERMAL development factor imp-L2protein2073% helix, 51% strandQ09024
BNEURAL/ECTODERMAL development factor imp-L2protein2061% helix, 52% strandQ09024

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12280.590.8028GOL
23410.580.7634empty
31400.410.7424empty
4510.290.7516empty

Interfaces

1 interface between chains.

  • A–B · 982 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 modified, 4 disulfide (engineered, disulfide).

Compared structures

  • 4CBP · Crystal structure of neural ectodermal development factor IMP-L2. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q09024 · AlphaFold monomer V2.0 prediction for NEURAL/ECTODERMAL development factor imp-L2 (Q09024) · a predicted model of the same protein · chain B against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.